Recombinant poxvirus and streptococcal M protein vaccine
US5985654A · kind A · utility
19Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 3, 1994 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Mar 3, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/885
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Viruses of the family poxviridae such as vaccinia or fowlpox viruses are modified to contain a gene which expresses a protein corresponding to the conserved exposed region of the M6 protein. The modified products are useful as vaccines against streptococcal infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.